Skip to main content
Top
Published in: Trials 1/2016

Open Access 01-12-2016 | Research

The citation of relevant systematic reviews and randomised trials in published reports of trial protocols

Authors: Nikolaos Pandis, Padhraig S. Fleming, Despina Koletsi, Sally Hopewell

Published in: Trials | Issue 1/2016

Login to get access

Abstract

Background

It is important that planned randomised trials are justified and placed in the context of the available evidence. The SPIRIT guidelines for reporting clinical trial protocols recommend that a recent and relevant systematic review should be included. The aim of this study was to assess the use of the existing evidence in order to justify trial conduct.

Methods

Protocols of randomised trials published over a 1-month period (December 2015) indexed in PubMed were obtained. Data on trial characteristics relating to location, design, funding, conflict of interest and type of evidence included for trial justification was extracted in duplicate and independently by two investigators. The frequency of citation of previous research including relevant systematic reviews and randomised trials was assessed.

Results

Overall, 101 protocols for RCTs were identified. Most proposed trials were parallel-group (n = 74; 73.3%). Reference to an earlier systematic review with additional randomised trials was found in 9.9% (n = 10) of protocols and without additional trials in 30.7% (n = 31), while reference was made to randomised trials in isolation in 21.8% (n = 22). Explicit justification for the proposed randomised trial on the basis of being the first to address the research question was made in 17.8% (n = 18) of protocols. A randomised controlled trial was not cited in 10.9% (95% CI: 5.6, 18.7) (n = 11), while in 8.9% (95% CI: 4.2, 16.2) (n = 9) of the protocols a systematic review was cited but did not inform trial design.

Conclusions

A relatively high percentage of protocols of randomised trials involves prior citation of randomised trials, systematic reviews or both. However, improvements are required to ensure that it is explicit that clinical trials are justified and shaped by contemporary best evidence.
Appendix
Available only for authorised users
Literature
1.
go back to reference Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383:267–76.CrossRefPubMed Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383:267–76.CrossRefPubMed
2.
go back to reference Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86–9.CrossRefPubMed Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86–9.CrossRefPubMed
3.
go back to reference Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7:e1000251.CrossRefPubMedPubMedCentral Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7:e1000251.CrossRefPubMedPubMedCentral
5.
go back to reference Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan A-W, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3:e3081.CrossRefPubMedPubMedCentral Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan A-W, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3:e3081.CrossRefPubMedPubMedCentral
7.
go back to reference Chan A-W, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet. 2013;381:91–2.CrossRefPubMed Chan A-W, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet. 2013;381:91–2.CrossRefPubMed
8.
go back to reference Clarke M, Chalmers I. Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents? JAMA. 1998;280:280–2.CrossRefPubMed Clarke M, Chalmers I. Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents? JAMA. 1998;280:280–2.CrossRefPubMed
9.
go back to reference Clarke L, Clarke M, Clarke T. How useful are Cochrane reviews in identifying research needs? J Health Serv Res Policy. 2007;12:101–3.CrossRefPubMed Clarke L, Clarke M, Clarke T. How useful are Cochrane reviews in identifying research needs? J Health Serv Res Policy. 2007;12:101–3.CrossRefPubMed
10.
go back to reference Clarke M, Hopewell S. Many reports of randomised trials still don’t begin or end with a systematic review of the relevant evidence. J Bahrain Med Soc. 2013;24:145–7. Clarke M, Hopewell S. Many reports of randomised trials still don’t begin or end with a systematic review of the relevant evidence. J Bahrain Med Soc. 2013;24:145–7.
11.
go back to reference Robinson KA, Goodman SN. A systematic examination of the citation of prior research in reports of randomized, controlled trials. Ann Intern Med. 2011;154:50–5.CrossRefPubMed Robinson KA, Goodman SN. A systematic examination of the citation of prior research in reports of randomized, controlled trials. Ann Intern Med. 2011;154:50–5.CrossRefPubMed
12.
go back to reference Clarke M, Hopewell S, Chalmers I. Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet. 2010;376:20–1.CrossRefPubMed Clarke M, Hopewell S, Chalmers I. Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet. 2010;376:20–1.CrossRefPubMed
13.
go back to reference Clarke M, Li Y. The current state of knowledge, alongside recommendations for future research and practice. J Evid-Based Med. 2012;5:47.CrossRefPubMed Clarke M, Li Y. The current state of knowledge, alongside recommendations for future research and practice. J Evid-Based Med. 2012;5:47.CrossRefPubMed
14.
15.
go back to reference Getz KA, Zuckerman R, Cropp AB, Hindle AL, Krauss R, Kaitin KI. Measuring the incidence, causes and repercussions of protocol amendments. Drug Inf J. 2011;45:265–75. Getz KA, Zuckerman R, Cropp AB, Hindle AL, Krauss R, Kaitin KI. Measuring the incidence, causes and repercussions of protocol amendments. Drug Inf J. 2011;45:265–75.
16.
Metadata
Title
The citation of relevant systematic reviews and randomised trials in published reports of trial protocols
Authors
Nikolaos Pandis
Padhraig S. Fleming
Despina Koletsi
Sally Hopewell
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Trials / Issue 1/2016
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-016-1713-6

Other articles of this Issue 1/2016

Trials 1/2016 Go to the issue